Your session is about to expire
← Back to Search
Patient Priorities Care for Dementia (PPC-HD Trial)
N/A
Waitlist Available
Led By Aanand D Naik, MD
Research Sponsored by The University of Texas Medical Branch, Galveston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after 1 month from participant visit to primary care provider
Awards & highlights
PPC-HD Trial Summary
This trial will help determine if Patient Priorities Care is effective in improving care for Hispanics with dementia and multiple chronic conditions.
Who is the study for?
This trial is for Hispanic individuals with dementia and multiple chronic conditions who are patients at the UTMB Geriatrics Outpatient Clinic in Galveston. They must speak English or Spanish, consent to participate, and have a caregiver willing to join the study. Those not treated at this clinic, non-Hispanic, speaking other languages, without multiple chronic conditions or dementia are excluded.Check my eligibility
What is being tested?
The trial tests Patient Priorities Care (PPC), which aligns treatments with what matters most to patients rather than following standard guidelines for each disease. The goal is to see if PPC can be effectively integrated into healthcare systems serving large Hispanic populations.See study design
What are the potential side effects?
Since PPC involves personalized care plans based on patient priorities rather than medication or procedures, there aren't typical side effects like those seen with drugs; however, changes in treatment may affect each person differently.
PPC-HD Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ after 1 month from participant visit to primary care provider
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after 1 month from participant visit to primary care provider
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of participants with changes in medications documented in the electronic health record based on participants' health priorities
PPC-HD Trial Design
2Treatment groups
Experimental Treatment
Group I: Patient Priorities Care (PPC) AdaptationExperimental Treatment1 Intervention
5 Hispanic patients with multiple chronic conditions (MCC) and no dementia. In order to adapt PPC for Hispanics with MCC, five Hispanics with MCC will go through the 2 parts of the PPC approach: 1) Priority setting; and 2) Care alignment.
Group II: PPC Feasibility TestingExperimental Treatment1 Intervention
20 Hispanic patients with multiple chronic conditions (MCC), including dementia. In order to adapt PPC for Hispanics with MCC and dementia, twenty Hispanics with MCC and dementia will go through the 2 parts of the PPC approach: 1) Priority setting; and 2) Care alignment.
Find a Location
Who is running the clinical trial?
The University of Texas Medical Branch, GalvestonLead Sponsor
241 Previous Clinical Trials
56,577 Total Patients Enrolled
1 Trials studying Dementia
12 Patients Enrolled for Dementia
The University of Texas Health Science Center, HoustonOTHER
903 Previous Clinical Trials
320,956 Total Patients Enrolled
9 Trials studying Dementia
2,489 Patients Enrolled for Dementia
Aanand D Naik, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
3 Previous Clinical Trials
191 Total Patients Enrolled
1 Trials studying Dementia
50 Patients Enrolled for Dementia
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not have a diagnosis of dementia.I have not given my consent to participate in the study.I speak a language other than English or Spanish.I have been diagnosed with dementia.I have agreed to participate in this study, or someone has agreed for me if I'm unable.I have been diagnosed with dementia.
Research Study Groups:
This trial has the following groups:- Group 1: Patient Priorities Care (PPC) Adaptation
- Group 2: PPC Feasibility Testing
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this investigation open to new participants?
"This study, first posted on May 31st 2022 and last updated on August 24th 2022, is not searching for participants currently. Nevertheless, there are 420 other trials actively recruiting patients at the present time."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger